AST-1306 (TsOH) Size:Solid 2 mg Cloxacillin was discovered and developed

Cloxacillin was discovered and developed by Beecham

1-3(2)4/h8-10

Daily oral dosing of 50 mg/kg Ponatinib causes significant tumor regression (%T/C = 0

200 nM (EC80

InChiKey: UCRLQOPRDMGYOA-BWBYNRQYSA-L

AST-1306 (TsOH) Size:Solid 2 mg Cloxacillin was discovered and developedAllitinib, also known as AST1306 and ALS 1306, is a potent, selective, irreversible ErbB2 and EGFR inhibitor. AST 1306 inhibits the enzymatic activities of wild type epidermal growth factor receptor (EGFR) and ErbB2 as well as EGFR resistant mutant in both cell free and cell based systems. AST1306 was found to function as an irreversible inhibitor, most likely through covalent interaction with Cys797 and Cys805 in the catalytic domains of EGFR and